RESPONSIVENESS AND ACCEPTABILITY OF THE EQ-5D TO AN INTERNATIONAL RARE DISEASE COMMUNITY
Author(s)
Crossnohere N1, Fischer R2, Peay H3, Bridges JFP4
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, 2Parent Project Muscular Dystrophy (PPMD), Hackensack, NJ, USA, 3RTI International, Research Triangle Park, NC, USA, 4The Ohio State University College of Medicine, Columbus, OH, USA
OBJECTIVES : Regulatory agencies may share data internationally to inform decision-making regarding orphan drug treatments, giving local research potentially global impact. This study explores the responsiveness and acceptability of the widely-used EQ-5D in measuring health-status across an international sample of Duchenne muscular dystrophy patients and caregivers. METHODS : A community-engaged cohort study is documenting the experience of adults with Duchenne, caregivers of affected adults, and caregivers of minors from Australia, Belgium, Canada, Holland, United Kingdom, & United States (expected N=360). Participants completed the EQ-5D (3L, 3LProxy1, YProxy1). ANOVA tests explored QALY and VAS scores across respondent groups and country, and regression explored scores adjusted for patient-age and significant independent predictors. Z-tests of Likert-type items evaluated the EQ-5D for ease of understanding and answering, relevance, and reflection of “real health” in comparison with a 75% agreement-rate. RESULTS : A preliminary sample of 22 adults, 24 caregivers of adults, 69 caregivers of minors from Australia, UK, and US participated. QALY and VAS scores were predicted by participant role (P<0.001), but not by country (P>0.05). The mean QALY was 0.37 (range: 0.16, 0.79) for adults, 0.18 (-0.11, 0.67) for caregivers of adults, and 0.47 (-0.11, 1.0) for caregivers of minors. Adults reported QALY scores 20% higher than caregivers of adults (P=0.01) after age-adjustment. The mean VAS score was 79 (range: 30, 99) among adults, 55 (15, 90) among caregivers of adults, and 68 (30, 100) among caregivers of minors. Adults reported average VAS scores 24 points above caregiver groups after age adjustment (P<0.01). All groups met or exceeded the 75% instrument acceptability agreement-rate (P<0.05). CONCLUSIONS : EQ-5D was responsive and acceptable for this multi-national rare disease sample. While adults consistently rated their health higher than caregivers in preliminary data, the difference between groups was attenuated using the population-derived QALY estimates as compared to self-evaluation using the VAS.
Conference/Value in Health Info
2019-05, ISPOR 2019, New Orleans, LA, USA
Value in Health, Volume 22, Issue S1 (2019 May)
Code
PRO51
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities
Disease
Rare and Orphan Diseases